02/04/2015
https://www.congress.gov...
"Without the competition, of course, on the market, these spikes will go unchecked."
"a goal date is not binding."
"I believe that incentivizing new, safe, and effective generics and promoting competition is very important for Montanans and all Americans."
"reducing the barriers to generics entering the market would clearly help create other examples like Lipitor by reducing the turbulence we see in the market and decreasing costs."